Please use this identifier to cite or link to this item:
https://nslhd.intersearch.com.au/nslhdjspui/handle/1/42914Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Hilmer, Sarah Nicole | en |
| dc.date.accessioned | 2025-01-13T00:03:11Z | - |
| dc.date.available | 2025-01-13T00:03:11Z | - |
| dc.date.issued | 2024-12 | - |
| dc.identifier.issn | 2399-5300 | - |
| dc.identifier.uri | https://nslhd.intersearch.com.au/nslhdjspui/handle/1/42914 | - |
| dc.language.iso | en | en |
| dc.relation.ispartof | Innovation in Aging | en |
| dc.title | DRUG DEVELOPMENT AND EVALUATION: AGE, SEX, AND FRAILTY CONSIDERATIONS TO FACILITATE THE FORTITUDE FACTOR | en |
| dc.type | Other | en |
| dc.identifier.affiliation | Royal North Shore Hospital | en |
| dc.identifier.doi | 10.1093/geroni/igae098.1644 | - |
| dc.description.pages | 503–504 | en |
| dc.relation.url | https://academic.oup.com/innovateage/article/8/Supplement_1/503/7937670 | en |
| dc.publisher.place | 8(S1):503–504 | en |
| local.editedby.name | HN130125 | en |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.languageiso639-1 | en | - |
| item.fulltext | No Fulltext | - |
| item.openairetype | Other | - |
| item.grantfulltext | none | - |
| item.cerifentitytype | Publications | - |
| crisitem.author.dept | Royal North Shore Hospital | - |
| crisitem.author.dept | Aged Care | - |
| crisitem.author.dept | Clinical Pharmacology | - |
| Appears in Collections: | Research Publications | |
Items in NSLHD are protected by copyright, with all rights reserved, unless otherwise indicated.